Press Release
New England Doctor Sentenced for Drug Conspiracy
For Immediate Release
U.S. Attorney's Office, District of Vermont
Burlington, Vermont – A New England doctor was sentenced on April 14, 2025 to eight months in prison, followed by two years of supervised release, for conspiring to illegally distribute buprenorphine, a prescription opioid. The Court also ordered the forfeiture of $75,000, which reflects the proceeds Khan collected as a result of prescribing high-dose opioids over the course of the conspiracy, and a fine of $20,000. Additionally, as a result of this investigation, Khan has relinquished his medical license and DEA registrations. This was the first joint prosecution of a doctor by the United States Attorney’s Office for the District of Vermont and the United States Department of Justice, Criminal Division, Health Care Fraud Unit’s New England Strike Force.
According to court documents, in November 2024, Adnan S. Khan, M.D., 49, of Manchester, New Hampshire, pleaded guilty to conspiring with others to illegally distribute opioids through his business, New England Medicine and Counseling Associates (NEMCA), which operated a network of clinics in New England. Khan admitted that he and others agreed to require cash for purported office visits and falsify medical records to justify his illegal prescribing practices.
During the conspiracy, Khan emailed a co-conspirator a press release from the United States Department of Justice (“USDOJ”), announcing the creation of the New England Strike Force. In response, the co-conspirator stated that it is “clear that ‘making profit off of patients’ is geared towards folks like us. Curious where this will lead.” Khan then emailed NEMCA staff and stated that, “I have been informed that there is a new task force . . . [for the New England states] on the lookout for medical professionals who are prescribing scheduled meds [irresponsibly], etc.” In light of this, Khan warned his staff that, “It is not a matter of if someone from such a task force will visit NEMCA but rather a matter of time.” Khan then ordered his staff “NOT to engage or discuss anything [with the USDOJ’s New England Strike Force] about NEMCA, what we do, what we offer, fees, etc.”
Under the plea agreement, Khan admitted that he and a co-conspirator required patients—many of whom were economically disadvantaged—to pay $250 cash in exchange for opioid prescriptions. Khan then diverted funds that he earned from these patients for his personal use and benefit, including by purchasing an airplane and multiple properties in New England. Khan would also personally deposit the cash that he received from patients, including deposits in excess of $10,000, at his bank. If a patient could not afford the full cash payment, Khan agreed to lower the dosage of that patient’s prescription.
Khan also admitted that he and a co-conspirator discussed their concern that, because pharmacies were no longer willing to fill the prescriptions, NEMCA might lose “dishonest” patients, who were “selling their meds.” Khan said that their “honest patients” were “the smaller part of [NEMCA’s] clientele” and urged a co-conspirator, “it’s the diverters [of the drugs that] we need to try to figure out a way to retain.” A co-conspirator emailed Khan, suggesting that they give $100 “scholarships” to patients who owed them money. Khan responded, “Stuck on ‘who’ should get them. Shitbag patients owe me so much that $100 won’t even put a dent on their account and they probably won’t appreciate it. Maybe the borderline ones who are just over the $250 threshold? They would probably get on their knees in gratitude.”
Acting U.S. Attorney Michael P. Drescher for the District of Vermont made the announcement. The Department of Health and Human Services—Office of Inspector General, the Federal Bureau of Investigation, the Drug Enforcement Administration and the Vermont Attorney General’s Office Medicaid Fraud and Residential Abuse Unit, investigated the case.
Trial Attorneys Thomas D. Campbell and Danielle H. Sakowski of the Criminal Division’s Fraud Section and Assistant U.S. Attorney Andrew Gilman for the District of Vermont prosecuted the case.
The Fraud Section partners with federal and state law enforcement agencies and U.S. Attorneys’ Offices throughout the country to prosecute medical professionals and others involved in the illegal prescription and distribution of opioids. The Fraud Section leads the Criminal Division’s efforts to combat health care fraud through the Health Care Fraud Strike Force Program. Since March 2007, this program, currently comprised of nine strike forces operating in 27 federal districts, has charged more than 5,800 defendants who collectively have billed federal health care programs and private insurers more than $30 billion. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with HHS-OIG, are taking steps to hold providers accountable for their involvement in health care fraud schemes. More information can be found at www.justice.gov/criminal/criminal-fraud/health-care-fraud-unit.
Anyone needing access to opioid treatment services can contact HHS-OIG’s Substance Abuse and Mental Health Services Administration 24/7 National Helpline for referrals to treatment services at 1-800-662-4359.
Contact
Media Inquiries/Public Affairs Officer:
(802) 651-8250
Updated April 17, 2025
Topics
Drug Trafficking
Opioids
Prescription Drugs
Health Care Fraud
Component